Nature: A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
A A Harandi et al 2024 Scientific Reports Extracts Abstract […]
Research News
The Guardian: Long Covid and Mitochondrial Dysfunction
The Guardian: Long Covid and Mitochondrial Dysfunction Read More »
Expert researchers link ‘muscle damage’ and issues with metabolism to Long Covid patients who experience malaise following exercise.
ME Association Research Review: Post-Exertional Malaise (PEM) in ME/CFS and Long Covid
ME Association Research Review: Post-Exertional Malaise (PEM) in ME/CFS and Long Covid Read More »
Research evidence shows that the presence of PEM cannot be disputed and is not due to inactivity or deconditioning.
Medscape News: NIH Conference: New research aims to find treatments for ME/CFS and Long Covid
“The idea of this meeting is to try and identify pathways that will be treatable…”
The Guardian: ‘Long flu’ study finds flu patients at higher risk of longer-term illness
The Guardian: ‘Long flu’ study finds flu patients at higher risk of longer-term illness Read More »
“We need to stop trivialising viral infections and understand that they are major drivers of chronic diseases.”
ME/CFS and Long Covid Research: 5 – 11 December 2023
ME/CFS and Long Covid Research: 5 – 11 December 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
ME/CFS and Long Covid Research: 27 November – 04 December 2023
ME/CFS and Long Covid Research: 27 November – 04 December 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
ME/CFS and Long Covid Research: 21 – 27 November 2023
ME/CFS and Long Covid Research: 21 – 27 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
ME Association Research Review: Mortality in ME/CFS
ME Association Research Review: Mortality in ME/CFS Read More »
Malnutrition is the most serious life-threatening complication in those with ME/CFS, especially in very severe cases.
ME/CFS and Long Covid Research: 16 – 20 November 2023
ME/CFS and Long Covid Research: 16 – 20 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
ME/CFS and Long Covid Research: 06 – 15 November 2023
ME/CFS and Long Covid Research: 06 – 15 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
TIME Magazine: A new radical approach needed for Long COVID research
TIME Magazine: A new radical approach needed for Long COVID research Read More »
With no treatment or cure in sight for Long Covid patients, who is really to blame for 3 years of disappointing clinical research results?
Research: Long Covid treatment trial: Donepezil hydrochloride
Research: Long Covid treatment trial: Donepezil hydrochloride Read More »
The effect of donepezil hydrochloride on post-COVID memory impairment: A
ME/CFS and Long Covid Research: 31 October – 6 November 2023
ME/CFS and Long Covid Research: 31 October – 6 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
The ME Association raises concerns about new research promoting CBT as a treatment for ME/CFS
Medical Xpress has reported on the following published research ‘Cognitive
ME/CFS and Long Covid Research: 24 – 30 October 2023
ME/CFS and Long Covid Research: 24 – 30 October 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Researchers identify amino acid that may play a key role for predicting and treating Long Covid
Phase 3 trial of supplement proposed, new diagnostic tool to
The ME Association and ME Research UK announce funding for a study that aims to create a diagnostic test for ME/CFS
The ME Association and ME Research UK are funding a new study using nanoelectronic testing which could produce a diagnostic marker for people with ME/CFS.
Research: Amitriptyline nearly doubles IBS symptom improvement
Research: Amitriptyline nearly doubles IBS symptom improvement Read More »
In a phase 3 clinical trial, Amitriptyline was superior to placebo as a second-line treatment for IBS in primary care.
ME/CFS and Long Covid Research: 17 – 23 October 2023
ME/CFS and Long Covid Research: 17 – 23 October 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.